Weekly updating of guideline recommendations was feasible: the Australian National COVID-19 clinical evidence Taskforce.

ABSTRACT:

Objectives

To investigate how quickly evidence was incorporated into the Australian living guidelines for COVID-19 during the first 12 months of the pandemic.

Study design and setting

For each study concerning drug therapies included in the guideline from April 3, 2020 to April 1, 2021, we extracted the publication date of the study, and the guideline version the study was included in. We analyzed two subgroups of studies as follows: those published in high impact factor journals and those with 100 or more participants.

Results

In the first year, we published 37 major versions of the guidelines, incorporating 129 studies that investigated 48 drug therapies informing 115 recommendations. The median time from first publication of a study to incorporation in the guidelin

SUBMITTER: Hewitt J 

PROVIDER: S-EPMC9939393 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature